Efficacy and safety of GLP-1 receptor agonists and SGLT2 inhibitors as adjuncts to insulin in type 1 diabetes: Systematic review and meta-analysis.

Abdel-Rahman, Sama M et al.·Diabetes·2026·
RPEP-146892026RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Efficacy and safety of GLP-1 receptor agonists and SGLT2 inhibitors as adjuncts to insulin in type 1 diabetes: Systematic review and meta-analysis.
Published In:
Diabetes, obesity & metabolism (2026)
Database ID:
RPEP-14689

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-14689·https://rethinkpeptides.com/research/RPEP-14689

APA

Abdel-Rahman, Sama M; Al-Shiab, Rama; Shah, Ermeena; Güldan, Mustafa; Ak, Ahmet Bahadır; Yilmaz, Zeynep Y; Fidan, Derya Göksu; Ozbek, Lasin; Kanbay, Mehmet. (2026). Efficacy and safety of GLP-1 receptor agonists and SGLT2 inhibitors as adjuncts to insulin in type 1 diabetes: Systematic review and meta-analysis.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.70506

MLA

Abdel-Rahman, Sama M, et al. "Efficacy and safety of GLP-1 receptor agonists and SGLT2 inhibitors as adjuncts to insulin in type 1 diabetes: Systematic review and meta-analysis.." Diabetes, 2026. https://doi.org/10.1111/dom.70506

RethinkPeptides

RethinkPeptides Research Database. "Efficacy and safety of GLP-1 receptor agonists and SGLT2 inh..." RPEP-14689. Retrieved from https://rethinkpeptides.com/research/abdel-rahman-2026-efficacy-and-safety-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.